Khat chewing and health related quality of life: Cross-sectional study in Jazan region, Kingdom of Saudi Arabia

Health and Quality of Life Outcomes

Volumn 12, Issue 1, 2014, Pages

  Sheikh, Kamaludin A ^a   El setouhy, Maged ^a,d   Yagoub, Umar ^b   Alsanosy, Rashad ^a   Ahmed, Zafar ^c  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b Defense Ministry   (Saudi Arabia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

FS 36 questionnaire; Health related quality of life; Khat chewing

Indexed keywords

CATHA EDULIS EXTRACT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MASTICATION; MIDDLE AGED; PATIENT ATTITUDE; QUALITY OF LIFE; RANK SUM TEST; REPRODUCIBILITY; SAUDI ARABIA; SHORT FORM 36; SOCIAL STATUS; YOUNG ADULT;

ADOLESCENT; ADULT; CATHA; CROSS-SECTIONAL STUDIES; HEALTH STATUS; HUMANS; MALE; MARITAL STATUS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SAUDI ARABIA; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84897959087     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-12-44     Document Type: Article

References (67)

1. Gebissa E. Khat in the Horn of Africa: historical perspectives and current trends. J Ethnopharmacol 2010, 132:607-614. 10.1016/j.jep.2010.01.063, 20227478.
2. Luqman W, Danowski TS. The use of khat (Catha edulis) in Yemen. Social and medical observations. Ann Intern Med 1976, 85:246-249. 10.7326/0003-4819-85-2-246, 942147.
3. Dhaifalah I, Santavy J. Khat habit and its health effect. A natural amphetamine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004, 148:11-15. 10.5507/bp.2004.002, 15523540.
4. Drake PH. Khat-chewing in the Near East. Lancet 1988, 1:532-533.
5. Griffiths P, Lopez D, Sedefov R, Gallegos A, Hughes B, Noor A, Royuela L. Khat use and monitoring drug use in Europe: the current situation and issues for the future. J Ethnopharmacol 2010, 132:578-583. 10.1016/j.jep.2010.04.046, 20452413.
6. Pennings EJ, Opperhuizen A, van Amsterdam JG. Risk assessment of khat use in the Netherlands: a review based on adverse health effects, prevalence, criminal involvement and public order. Regul Toxicol Pharmacol 2008, 52:199-207. 10.1016/j.yrtph.2008.08.005, 18783727.
7. Al-Samarraie M, Khiabani HZ, Opdal MS. Khat-a new drug of abuse in Norway. Tidsskr Nor Laegeforen 2007, 127:574-576.
8. Klein A. Khat in the neighbourhood-local government responses to khat use in a London community. Subst Use Misuse 2008, 43:819-831. 10.1080/10826080701738976, 18473224.
9. Osman FA, Soderback M. Perceptions of the use of khat among Somali immigrants living in Swedish society. Scand J Public Health 2011, 39:212-219. 10.1177/1403494810384908, 21056954.
10. Stefan J, Mathew B. Khat chewing: an emerging drug concern in Australia?. Aust N Z J Psychiatry 2005, 39:842-843.
11. Douglas H, Boyle M, Lintzeris N. The health impacts of khat: a qualitative study among Somali-Australians. Med J Aust 2011, 195:666-669. 10.5694/mja11.10166, 22171861.
12. Douglas H, Pedder M. Legal regulation of the drug khat in Australia. J Law Med 2010, 18:284-301.
13. Kroll J, Yusuf AI, Fujiwara K. Psychoses, PTSD, and depression in Somali refugees in Minnesota. Soc Psychiatry Psychiatr Epidemiol 2011, 46:481-493. 10.1007/s00127-010-0216-0, 20354676.
14. Chappell JS, Lee MM. Cathinone preservation in khat evidence via drying. Forensic Sci Int 2010, 195:108-120. 10.1016/j.forsciint.2009.12.002, 20036789.
15. Laussmann T, Meier-Giebing S. Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography. Forensic Sci Int 2010, 195:160-164. 10.1016/j.forsciint.2009.12.013, 20047807.
16. Hagel JM, Krizevski R, Kilpatrick K, Sitrit Y, Marsolais F, Lewinsohn E, Facchini PJ. Expressed sequence tag analysis of khat (Catha edulis) provides a putative molecular biochemical basis for the biosynthesis of phenylpropylamino alkaloids. Genet Mol Biol 2011, 34:640-646. 3229120, 22215969.
17. Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int 2005, 153:99-101. 10.1016/j.forsciint.2005.04.023, 15919169.
18. Al-Akwa AA, Shaher M, Al-Akwa S, Aleryani SL. Free radicals are present in human serum of Catha edulis Forsk (Khat) abusers. J Ethnopharmacol 2009, 125:471-473. 10.1016/j.jep.2009.07.012, 19619634.
19. Kalix P. Catha edulis, a plant that has amphetamine effects. Pharm World Sci 1996, 18:69-73. 10.1007/BF00579708, 8739260.
20. Widler P, Mathys K, Brenneisen R, Kalix P, Fisch HU. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmacol Ther 1994, 55:556-562. 10.1038/clpt.1994.69, 7910126.
21. Adeoya-Osiguwa SA, Fraser LR. Cathine and norephedrine, both phenylpropanolamines, accelerate capacitation and then inhibit spontaneous acrosome loss. Hum Reprod 2005, 20:198-207.
22. Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat). Expert Opin Drug Saf 2005, 4:1145-1154. 10.1517/14740338.4.6.1145, 16255671.
23. Ali WM, Zubaid M, Al-Motarreb A, Singh R, Al-Shereiqi SZ, Shehab A, Rashed W, Al-Sagheer NQ, Saleh AH, Al Suwaidi J. Association of khat chewing with increased risk of stroke and death in patients presenting with acute coronary syndrome. Mayo Clin Proc 2010, 85:974-980. 10.4065/mcp.2010.0398, 2966360, 20926835.
24. Balint EE, Falkay G, Balint GA. Khat - a controversial plant. Wien Klin Wochenschr 2009, 121:604-614. 10.1007/s00508-009-1259-7, 19921126.
25. Getahun W, Gedif T, Tesfaye F. Regular Khat (Catha edulis) chewing is associated with elevated diastolic blood pressure among adults in Butajira, Ethiopia: a comparative study. BMC Public Health 2010, 10:390. 10.1186/1471-2458-10-390, 2912809, 20594361.
26. Al-Motarreb A, Al-Kebsi M, Al-Adhi B, Broadley KJ. Khat chewing and acute myocardial infarction. Heart 2002, 87:279-280. 10.1136/heart.87.3.279, 1767022, 11847175.
27. Saha S, Dollery C. Severe ischaemic cardiomyopathy associated with khat chewing. J R Soc Med 2006, 99:316-318. 10.1258/jrsm.99.6.316, 1472730, 16738376.
28. Ali WM, Al Habib KF, Al-Motarreb A, Singh R, Hersi A, Al Faleh H, Asaad N, Al Saif S, Almahmeed W, Sulaiman K, Amin H, Al-Lawati J, Al Bustani N, Al-Sagheer NQ, Al-Qahtani A, Al Suwaidi J. Acute coronary syndrome and khat herbal amphetamine use: an observational report. Circulation 2011, 124:2681-2689. 10.1161/CIRCULATIONAHA.111.039768, 22155995.
29. Oyungu E, Kioy PG, Patel NB. Effect of Catha edulis (khat) on behaviour and its potential to induce seizures in Sprague Dawley rats. East Afr Med J 2007, 84:219-225.
30. Toennes SW, Kauert GF. Driving under the influence of khat-alkaloid concentrations and observations in forensic cases. Forensic Sci Int 2004, 140:85-90. 10.1016/j.forsciint.2003.11.028, 15013169.
31. Numan N. Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 2004, 99:61-65. 10.1111/j.1360-0443.2004.00570.x, 14678063.
32. Al-Sanosy RM. Pattern of khat abuse and academic performance among secondary school and college students in Jazan region, kingdom of Saudi Arabia (KSA). J Fam Community Med 2009, 16:89.
33. Ageely HM. Prevalence of Khat chewing in college and secondary (high) school students of Jazan region, Saudi Arabia. Harm Reduct J 2009, 6:11. 10.1186/1477-7517-6-11, 2707373, 19545389.
34. Elsanosi R, Bani I, Ageely H, Milaat W, El-Najjar M, Makeen A, Yagob U. Socio-medical problem of the habituation of Khat chewing in Jazan region in Southern Saudi Arabia. Eur J Sci Res 2011, 63:122-133.
35. McClave AK, Dube SR, Strine TW, Mokdad AH. Associations between health-related quality of life and smoking status among a large sample of US adults. Prev Med 2009, 48:173. 10.1016/j.ypmed.2008.11.012, 19103219.
36. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Int Med 1993, 118:622. 10.7326/0003-4819-118-8-199304150-00009, 8452328.
37. Julious SA, George S, Campbell MJ. Sample sizes for studies using the short form 36 (SF-36). J Epidemiol Community Health 1995, 49:642. 10.1136/jech.49.6.642, 1060182, 8596102.
38. Walters SJ. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36. Health Qual Life Outcomes 2004, 2:26. 10.1186/1477-7525-2-26, 421748, 15161494.
39. National Toxicology Program NTP Toxicology and Carcinogenesis Studies of Pentaerythritol Tetranitrate (CAS No. 78-11-5) with 80% D-Lactose Monohydrate (PETN, NF) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 1989, 365:1-190. National Toxicology Program.
40. Substance Abuse Research Center (SARC) Cigarette smoking as a risk factor in men with a prior history of myocardial infarction. J Chronic Dis 1979, 32:415-425. Substance Abuse Research Center (SARC).
41. Fischer W. Are DRGs homogeneous with regard to resource consumption. Paper Presented at the 16th Annual PCS/E Conference, Washington, DC 2000,
42. Palmer G, Reid B. Evaluation of the performance of diagnosis-related groups and similar casemix systems: methodological issues. Health Serv Manage Res 2001, 14(2):71-81. 10.1258/0951484011912564, 11373998.
43. Cox G, Rampes H. Adverse effects of khat: a review. Adv Psychiatr Treat 2003, 9:456-463.
44. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997, 4(5):231-244. 10.3109/10673229709030550, 9385000.
45. Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res 2001, 16:457-469. 10.1093/her/16.4.457, 11525392.
46. Elmi AS. The chewing of khat in Somalia. J Ethnopharmacol 1983, 8:163-176. 10.1016/0378-8741(83)90052-1, 6139513.
47. Hansen P. The ambiguity of khat in Somaliland. J Ethnopharmacol 2010, 132:590-599. 10.1016/j.jep.2010.02.028, 20211235.
48. Wedegaertner F, Al-Warith H, Hillemacher T, Te Wildt B, Schneider U, Bleich S, Breitmeier D. Motives for khat use and abstinence in Yemen-a gender perspective. BMC Public Health 2010, 10:735. 10.1186/1471-2458-10-735, 3006386, 21110889.
49. Hawkins JD, Lishner DM, Catalano RF. Childhood predictors and the prevention of adolescent substance abuse. NIDA Res Monogr 1985, 56:75-126.
50. Steinberg L. Adolescent transitions and alcohol and other drug use prevention. Preventing Adolescent Drug Use: From Theory to Practice 1991, 13-51.
51. Richardson L, Wood E, Li K, Kerr T. Factors associated with employment among a cohort of injection drug users. Drug Alcohol Rev 2010, 29:293-300. 10.1111/j.1465-3362.2009.00141.x, 20565522.
52. Manghi RA, Broers B, Khan R, Benguettat D, Khazaal Y, Zullino DF. Khat use: lifestyle or addiction?. J Psychoactive Drugs 2009, 41:1-10. 10.1080/02791072.2009.10400669, 19455904.
53. Corkery JM, Schifano F, Oyefeso A, Ghodse AH, Tonia T, Naidoo V, Button J. Overview of literature and information on" khat-related" mortality: a call for recognition of the issue and further research. Ann Ist Super Sanita 2011, 47:445-464.
54. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep 2002, 117:S135. 1913691, 12435837.
55. Torrance N, Smith BH, Lee AJ, Aucott L, Cardy A, Bennett MI. Analysing the SF-36 in population-based research A comparison of methods of statistical approaches using chronic pain as an example. J Eval Clin Pract 2009, 15:328-334. 10.1111/j.1365-2753.2008.01006.x, 19335493.
56. Daeppen JB, Krieg MA, Burnand B, Yersin B. MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients. Am J Drug Alcohol Abuse 1998, 24:685-694. 10.3109/00952999809019617, 9849778.
57. Heslin KC, Stein JA, Heinzerling KG, Pan D, Magladry C, Hays RD. Clinical correlates of health-related quality of life among opioid-dependent patients. Qual Life Res 2011, 20:1205-1213. 10.1007/s11136-011-9858-y, 3178032, 21328090.
58. Colpaert K, De Maeyer J, Broekaert E, Vanderplasschen W. Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug-and dual-dependent persons in residential treatment. Eur Addict Res 2013, 19:173-183. 10.1159/000343098, 23257413.
59. Cayuela A, Rodríguez-Domínguez S, Otero R. Deteriorated health-related quality of life in healthy male smokers. Archivos de Bronconeumología ((English Edition)) 2007,
60. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuringphysical and mental health constructs. Med Care 1993, 31(3):247-263. 10.1097/00005650-199303000-00006, 8450681.
61. Dhadphale M, Omolo O. Psychiatric morbidity among khat chewers. East Afr Med J 1988, 65:355-359.
62. Critchlow S, Seifert R. Khat-induced paranoid psychosis. Br J Psychiatry 1987, 150:247-249. 10.1192/bjp.150.2.247, 3651681.
63. Alem A, Shibre T. Khat induced psychosis and its medico-legal implication: a case report. Ethiop Med J 1997, 35:137.
64. Pantelis C, Hindler CG, Taylor JC. Use and abuse of khat (Catha edulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol Med 1989, 19:657-668. 10.1017/S0033291700024259, 2572026.
65. Brenneisen R, Fisch H, Koelbing U, Geisshusler S, Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol 2012, 30:825-828.
66. James Giannini A, Castellani S. A manic-like psychosis due to Khat Catha edulis Forsk. Clin Toxicol 1982, 19:455-459.
67. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use 2008, USA: Oxford University Press.